Imprivata, which provides secure access management software for the health care industry, announced terms for its IPO on Wednesday. The company's OneSign platform eliminates multiple log-ons and allows physicians, nurses and staff easy and secure access to healthcare systems across devices. The Lexington, MA-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 to $16. At the midpoint of the proposed range, it would command a fully diluted market value of $387 million.
Imprivata, which was founded in 2001 and booked $76 million in sales for the 12 months ended March 31, 2014, plans to list on the NYSE under the symbol IMPR. It initially filed confidentially on January 17, 2014. J.P. Morgan, Piper Jaffray are the joint bookrunners on the deal. It is expected to price during the week of June 23, 2014.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.